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iral fusion proteins of classes I and II differ radi-
cally in their initial structures but refold toward
similar conformations upon activation. Do fusion
pathways mediated by alphavirus E1 and inﬂuenza virus
hemagglutinin (HA) that exemplify classes II and I differ
to reﬂect the difference in their initial conformations, or
concur to reﬂect the similarity in the ﬁnal conformations
 
?
 
Here, we dissected the pathway of low pH–triggered E1-
mediated cell–cell fusion by reducing the numbers of acti-
vated E1 proteins and by blocking different fusion stages
V
 
with speciﬁc inhibitors. The discovered progression from
transient hemifusion to small, and then expanding, fusion
pores upon an increase in the number of activated fusion
proteins parallels that established for HA-mediated fusion.
We conclude that proteins as different as E1 and HA
drive fusion through strikingly similar membrane interme-
diates, with the most energy-intensive stages following
rather than preceding hemifusion. We propose that fusion
reactions catalyzed by all proteins of both classes follow
a similar pathway.
 
Introduction
 
Membrane fusion reactions mediated by diverse fusion pro-
teins are crucial for eukaryotic cells and for development of
multicellular organisms (Jahn et al., 2003; Shemer and Pod-
bilewicz, 2003). Recent studies on the diversity of fusion pro-
teins have focused on proteins that mediate fusion by which
enveloped viruses deliver their genome into host cells. Influ-
enza and Sindbis viruses are among the best-studied prototypes
of fusion machinery. For both viruses, fusion is triggered by
acidification of the virus-containing endosome. In the case of
influenza virus, low pH triggers restructuring in a homotri-
meric glycoprotein HA (Skehel and Wiley, 2000; Tamm, 2003;
Earp et al., 2005). In the case of Sindbis virus (SIN), a 1:1:1
arrangement of three structural proteins (the fusogenic envelope
glycoprotein E1, the accessory envelope glycoprotein E2, and
the capsid protein C) forms a double-shelled icosahedron
(Paredes et al., 1998). Low pH releases SIN E1 from its het-
erodimeric interaction with E2 and induces homotrimerization
of E1. The final lowest-energy forms of E1, HA, and many
other fusion proteins share an important motif, two sequences
that interact with membranes: the fusion peptide and the trans-
membrane domain relocate to the same end of the rodlike mol-
ecule (Weber et al., 1998; Skehel and Wiley, 2000; Gibbons et
al., 2003, 2004b; Bressanelli et al., 2004; Modis et al., 2004).
Restructuring of HA and E1 under fusion conditions involves
early reversible conformations (Leikina et al., 2002; Gibbons et
al., 2004a) and lateral interactions between adjacent proteins
(Markovic et al., 2001; Gibbons et al., 2004b).
In spite of the similarities, HA and E1 differ radically in
their initial structures and have come to represent two diver-
gent classes of viral fusion proteins (Lescar et al., 2001).
Class I proteins (exemplified by HA and HIV gp120/gp41)
are oriented perpendicularly to the envelope surface and fea-
ture 
 
 
 
-helical coiled-coil domains. A highly conserved and
critical for fusion “fusion peptide” sequence is located at or
near the NH
 
2
 
 terminus of the fusion protein. Class II proteins
(for instance, the E1 protein of alphaviruses such as SIN and
Semliki Forest virus [SFV] and the E protein of flaviviruses)
lie tangential to the virus membrane and have an “internal”
rather than “terminal” fusion peptide. Class II proteins contain
predominantly 
 
 
 
-strand secondary structures and are not pre-
dicted to form coiled-coils.
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ing fusion pores; RH, restricted hemifusion; RFD, rhodamine-tagged FD; SFV,
Semliki Forrest virus; SIN, Sindbis virus; UH, unrestricted hemifusion; ZnAS,
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Restructuring that brings proteins of classes I and II from
dissimilar initial conformations to similar final structures drive
membrane fusion. Fusion pathway mediated by class I proteins
has been dissected in experiments in which fusion was slowed
down or blocked at different stages by genetically modifying
fusion proteins or decreasing their numbers and by using spe-
cific inhibitors (Kemble et al., 1994; Chernomordik et al.,
1998; Kozerski et al., 2000; Melikyan et al., 2000; Russell et
al., 2001; Borrego-Diaz et al., 2003; Park et al., 2003). For HA,
progress through the fusion pathway toward the opening of an
expanding fusion pore connecting an HA-expressing cell and a
bound RBC is controlled by the surface density of HA (for re-
view see Chernomordik and Kozlov, 2003). Upon an increase
in the numbers of activated HAs, there is a shift in the observed
fusion phenotypes from restricted hemifusion (RH), in which
lipid flow through the hemifusion connections is restricted by
the proteins surrounding the fusion site, to unrestricted hemifu-
sion (UH), defined as lipid mixing without content mixing.
Only at very high densities of activated HAs does the fusion re-
action reach an irreversible stage of fusion pore expansion.
Although, in contrast to the pathway mediated by class I
proteins, the fusion pathway for class II proteins has not been
explored, fusion mediated by alphaviruses and flaviviruses has
been systematically characterized using mainly an experimen-
tal system of viral particles fusing with liposomes (White and
Helenius, 1980; Bron et al., 1993; Nieva et al., 1994; Kielian et
al., 1996; Corver et al., 1997; Smit et al., 1999, 2002; McIner-
ney et al., 2004). Fusion mediated by class II proteins is signif-
icantly faster, less sensitive to lowering of the temperature, and
less leaky than fusion reactions mediated by viruses with class
I fusion proteins (for instance, influenza virus) (Shangguan et
al., 1996; Corver et al., 2000; Smit et al., 2002). These differ-
ences along with dissimilarities between the starting conforma-
tions of the class I and II proteins might indicate that protein-
and membrane-restructuring for these two classes proceed by
distinct pathways. On the other hand, the similarity between
the post-fusion structures has suggested the similarity between
the fusion pathways (Gibbons et al., 2004b; Modis et al., 2004).
Do proteins of different classes catalyze fusion via radi-
cally different pathways? For instance, very robust fusion me-
diated by class II proteins might proceed through the entirely
proteinaceous fusion pore as proposed for some fusion events
(Lindau and Almers, 1995; Peters et al., 2001; Han et al., 2004)
rather than through hemifusion intermediates similar to those
in HA fusion (Kemble et al., 1994; Melikyan et al., 1997a;
Chernomordik and Kozlov, 2003). Within the fusion-through-
hemifusion pathway, rate-limiting stages in fusion progression
and, thus, “job description” of fusion proteins might vary: pro-
teins might be driving the entire pathway, as is the case for HA,
or, alternatively, act only to catalyze hemifusion with subse-
quent fusion stages to proceed spontaneously.
In this work, we found that cell fusion mediated by E1 of
SIN and SFV proceeds through intermediates strikingly similar
to those identified earlier for HA fusion. Only a fraction of all
low pH–activated E1s needed for fusion is required in order to
locally merge the contacting monolayers of two membranes
into RH intermediates. Additional activated E1s drive transi-
tion from RH into UH phenotype that allows lipid mixing be-
tween the membranes. Still greater numbers of activated E1s
advance fusion beyond transient hemifusion intermediates to
an opening and then to expansion of a fusion pore. The depen-
dence of the fusion phenotype on the number of activated E1s
indicates that the most demanding part of the job for fusion
proteins of class II, as for those of class I, follows rather than
precedes a local membrane merger.
 
Results
 
Unrestricted hemifusion, small fusion 
pores, and expanding fusion pores in SIN 
E1-mediated fusion
 
To study the pathway of E1-fusion for HAb2 cells that were
used in the work on HA-fusion (Danieli et al., 1996; Cherno-
mordik et al., 1998) we infected these cells with SIN. HAb2
cells express the immature HA0 form of the HA. HA0, al-
though competent to mediate binding with sialic acid receptors,
acquires fusogenic activity only if cleaved by trypsin into the
mature HA1-HA2 form. SIN-infected HAb2 cells (referred to
below as E1-HAb2 cells), used without trypsin pretreatment
and thus having only the fusion-incompetent HA0 form, were
incubated with RBCs labeled with the lipid probe PKH26 and
different aqueous probes.
Application of pH 5.6 to E1-HAb2/RBC pairs caused ro-
bust lipid and content mixing (Fig. 1). No fusion was observed
at neutral pH (C1) or for noninfected HA0-expressing HAb2
cells treated with pH 5.6 (C2) or pH 4.9 (not depicted). Note
Figure 1. Fusion phenotypes at different pH. Fusion of SIN E1-HAb2
cells with bound PKH26- and CF- or FD-labeled RBCs was triggered by a
5-min application of different pH: pH 5.6, 6.0, 6.2, and 6.5. Here and in
other figures final extents of lipid mixing and CF and FD transfer assayed
at neutral pH are shown by red, green, and blue bars, respectively. In the
control experiments we either did not apply low pH (C1) or replaced SIN
E1-HAb2 cells with uninfected HAb2 cells, pH 5.6 (C2). Here and in the
subsequent figures bars are mean   SD, n   3. The inset shows the rela-
tive frequency of UH phenotype among all lipid mixing events and NEP
phenotype among all CF mixing events (see Materials and methods) for
different pH. 
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that E1 fusion is triggered at less acidic pH than HA fusion.
Even for HAb2 cells with fully cleaved HA, pH 5.6 application
gave no measurable fusion (not depicted; see also Cherno-
mordik et al., 1998). These controls confirmed that fusion be-
tween E1-HAb2 cells and RBCs is mediated by low pH forms
of SIN E1.
The less acidic the pH applied, the lower is the percent-
age of alphavirus E1 that undergoes conformational restruc-
turing into functional E1 homotrimers (Sjoberg and Garoff,
2003). By shifting pH applied to E1-HAb2/RBC pairs to pH
 
 
 
5.6 we gradually decreased fusion extents and, more impor-
tantly, detected two phenotypes of partial fusion. The dif-
ference between fusion extents detected as transfer of 6-car-
boxyfluorescein (CF) and transfer of a larger aqueous probe,
70-kD fluorescent dextran (FD) (Fig. 1, green vs. blue bars),
indicated that some cell pairs developed small, nonexpanding
fusion pores (NEP). Similarly, the difference between lipid
and CF mixing extents (Fig. 1, red vs. green bars) indicated
that some cell pairs developed lipid mixing without content
mixing, i.e., UH.
To test whether UH connections are stable or dissociate
with time we analyzed the kinetics and final extents of lipid
mixing. Fusion events yielding both lipid and CF transfer re-
sulted in complete lipid mixing defined by lack of a distinct cir-
cular shape of the RBC at the end of the experiment (Fig. 2). In
contrast, most of the E1-HAb2/RBC pairs that demonstrated
UH presented a “partial lipid mixing” phenotype (Mittal et al.,
2003), where lipid dye transfer remains incomplete at the end
of the lipid mixing process. Because UH yields partial rather
than complete lipid mixing and, thus, lipid flow through UH
connections stops before its completion, we conclude that these
connections spontaneously dissociate.
Note that in the experiments shown in Fig. 2 fusion was
not only triggered but also was observed in the low pH medium.
Thus, a return to neutral pH after low pH application was not re-
quired for fusion in our experimental system. This finding con-
tradicts the conclusions reached in Paredes et al. (2004), but is
consistent with the conclusion reported in Waarts et al. (2002).
 
Transient restricted hemifusion
 
Both UH and RH connections can be transformed into com-
plete fusion by a short-term application of chlorpromazine
(CPZ). This cationic amphipath preferentially partitions into
and destabilizes the inner membrane monolayers, which form
the hemifusion structure (Melikyan et al., 1997a). To test
whether E1 is capable of forming RH, E1-HAb2/RBC pairs
were first treated with a low pH pulse and then, already at neu-
tral pH, with a 1-min CPZ pulse (Fig. 3). CPZ pulse caused a
significant increase in the extent of both lipid and content mix-
ing in comparison with controls observed after the low pH
pulse without CPZ application. CPZ-induced fusion promotion
was less profound for lower pH (Fig. 3 B vs. Fig. 3 A) because
fusion has proceeded further at the lower pH.
RH intermediates were formed by the low-pH–activated
E1. Neither lipid nor content mixing was promoted when CPZ
was applied to E1-HAb2 /RBC pairs not exposed to low pH or
to low-pH–treated noninfected HAb2 cells with bound RBCs.
The significant decrease in the fusion promotion, when CPZ
was applied 40 min after the low-pH pulse (Fig. 3), indicates
that RH is a transient intermediate that either dissociates
(Leikina and Chernomordik, 2000) or shifts to an yet unidenti-
fied non-CPZ sensitive forms of hemifusion.
To summarize, at suboptimal pH, when the number of
activated E1 proteins is insufficient to form an expanding fu-
sion pore, E1 establishes less advanced fusion phenotypes, two
types of transient hemifusion intermediates (RH and UH) and
small fusion pores. Even when fusion did not reach irrevers-
ible stage of expanding fusion pore, RBCs remained associ-
ated with HA-cells via HA1-receptor binding (Chernomordik
et al., 1998).
 
E1-mediated fusion in the absence of HA0
 
The fusion phenotypes observed for E1-HAb2 fusion can be
observed in the absence of any forms of HA. Labeled RBCs
were allowed to settle onto attached SIN-infected BHK21 cells.
Figure 2. Partial lipid mixing in E1 fusion. (A) Bright-field and fluorescent
images for two SIN E1-HAb2 cell/RBC pairs represent the two phenotypes
of lipid mixing. Bright-field images with RBCs marked by arrows were
taken after low pH application. Full lipid mixing (top) is defined by lack of
a distinct circular shape of the RBC at the end of the experiment, when
dye transfer reaches the saturation (t   Final). Partial lipid mixing (bottom)
is defined by incomplete dye transfer with a clear boundary of the initial
RBC membrane seen at the time when lipid mixing reaches its saturation.
PKH26 fluorescence spreads from RBCs (bright spot at the time the pH is
lowered to 6.0, t   0) to the E1-HAb2 cell (dark at t   0 and fluorescent
at t   Final) upon completion of the lipid mixing event. Right images show
CF fluorescence at t   Final. (B) The percentages of E1-HAb2/RBC pairs
showing at pH 6.0 any lipid mixing, full lipid mixing, and content (CF)
mixing were measured. Cell pairs that show some but not full lipid mixing
presented partial lipid mixing phenotype. The percentage of cells with full
lipid mixing phenotype is close to the percentage of cells showing CF
transfer. The data were collected in four independent experiments. The total
number of cell pairs ( 100%) in the analysis was 250. 
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In contrast to E1-HAb2 cells, infected BHK21 cells have no
mechanism of RBC binding. However, gentle replacement of
the medium with RBC-free low pH buffer allowed us to ob-
serve fusion between infected BHK21 cells and loosely at-
tached RBCs. Although the lack of tight RBC binding hindered
quantification of E1 fusion in this system, we did observed
complete fusion (transfer of both PKH26 and FITC-tagged FD
[FFD]), the NEP phenotype (transfer of CF but not of rho-
damine-tagged FD [RFD]), UH, and RH after application of
suboptimal pH (unpublished data).
 
Fusion phenotypes formed by SFV E1
 
The fusion phenotypes described above for cells infected with
SIN were also observed for cells transfected with a plasmid en-
Figure 3. RH in SIN E1 fusion. Fusion of SIN E1-HAb2 cells with bound PKH26- and CF-labeled RBCs was triggered by a 5-min pulse of pH 6.5 (A) or
pH 6.0 (B). Bars 1: the final extents of lipid and CF mixing. Bars 2 and 3: hemifusion connections were transformed into complete fusion by a 1-min pulse
of 0.5 mM CPZ applied immediately after the low pH pulse (bars 2) or with a 40 min delay (bars 3). No lipid mixing was observed when CPZ was
applied to E1-HAb2/RBC pairs not exposed to acidic pH (C1) or to low-pH–treated noninfected HAb2 cells with bound RBCs (C2).
Figure 4. RH and UH phenotypes and nonexpanding fusion pores in SFV E1 fusion. (A) Bright-field and fluorescent images for two SFV E1-HAb2 cell/RBC
pairs after 5-min pulse of pH 6.0 represent the two phenotypes of lipid mixing: full lipid mixing correlated with content mixing (“fusion” in top panel) and
partial lipid mixing correlated with UH (bottom panel). Spreading of the PKH26 and CF fluorescence from RBCs (marked by arrow in bright-field image) to
the E1-HAb2 cell is shown upon completion of the lipid mixing event. (B) NEP phenotype observed in fusion between RBCs doubly labeled with CF and
70-kD RFD and bound SFV E1-HAb2 cell. Aqueous connection between the cells allows transfer of CF but not 70-kD RFD. (C) Low magnification images
(bright field, PKH26- and CF-fluorescence) of SFV E1-HAb2 cells with bound RBCs treated with 5-min pulse of pH 5.6 or 6.0 (top and middle panels,
respectively). Bottom panel shows the field of view for SFV E1-HAb2 cells with bound RBCs treated with 5-min pulse of pH 6.0 and then treated with a CPZ
pulse to transform RH into complete fusion. 
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coding the structural proteins of SFV. Raising the pH applied
to trigger fusion between transfected HAb2 cells (SFV E1-
HAb2 cells) and bound RBCs from pH 5.6 to pH 6.0 allowed
us to identify UH (Fig. 4 A, bottom), NEP (Fig. 4 B), and RH
(Fig. 4 C) phenotypes.
 
LPC-arrested stage
 
Additional phenotype of E1 fusion was identified using fusion
inhibitor lysophosphatidylcholine (LPC), a lipid that inhibits
diverse fusion reactions (Chernomordik et al., 1993; for review
see Chernomordik and Kozlov, 2003). To test LPC activity for
E1 fusion, E1-HAb2/RBC pairs were incubated with lauroyl
LPC for 5 min and then, still in the presence of LPC, treated
with a pH 6.0 pulse (Fig. 5). In contrast to the control with no
LPC present, we observed significant inhibition of fusion (Fig.
5 A, bars 2 vs. bars 1). Fusion commenced upon LPC removal
(Fig. 5 A, bars 3 vs. bars 1). Thus, the LPC-arrested fusion
stage (LAS) in E1 fusion precedes lipid and CF mixing, but fol-
lows low pH–dependent E1 activation.
As for E1-HAb2/RBC fusion, LPC inhibited fusion of
SIN-infected BHK21 cells with RBCs (Fig. 5 B). Importantly,
although there was no fusion when BHK21 cells with loosely at-
tached RBCs were treated with a low pH pulse in the presence of
LPC, after the pulse RBCs became tightly attached to the in-
fected cells. This low pH–dependent binding was mediated by
SIN glycoproteins, as evidenced by the lack of such RBC bind-
ing in the controls with SIN-infected cells untreated with low pH
and low pH–treated noninfected BHK21. Low pH–induced
binding between E1-expressing membrane and receptorless tar-
get membrane is known to be mediated by an insertion of an E1
fusion loop (FL) into the target membrane, a prerequisite for E1
homotrimerization and for fusion (Kielian et al., 1996; Smit et
al., 1999; Gibbons et al., 2004a). Our finding that low pH–depen-
dent binding between SIN-infected BHK21 cells and RBCs is
not affected in the presence of LPC indicates that fusion inhibi-
tion by LPC does not involve inhibition of the FL insertion.
In the experiments discussed above, LPC was added to
both fusing membranes. To further test whether fusion inhibi-
Figure 5. LAS that follows all low pH–dependent stages of E1 restructuring and precedes actual membrane fusion. (A) Cartoon to the right illustrates the
experimental protocol and our finding that LPC reversibly arrested fusion downstream low pH–dependent stages. Fusion between SIN E1-HAb2 cells and
bound RBCs was triggered by a 5-min pulse of pH 6.0 and assayed as lipid and CF mixing. Bars 1: No LPC added; Bars 2: starting 5 min before the low
pH pulse and throughout the entire experiment, cell pairs were incubated in the presence of 70  M lauroyl LPC. Bars 3: LPC was washed out by LPC-free
PBS 15 min after the end of low pH application. In the control experiments we applied and then removed LPC to E1-HAb2/RBC pairs that had not been
treated with a low pH pulse (C1); or applied a low pH pulse in the presence of LPC to uninfected HAb2 cells with bound RBCs and then washed out LPC
(C2). (B) SIN-infected BHK21 cells with loosely attached RBCs were treated with a 5-min pH 6.0 pulse in the absence (bars 1) or in the presence of 70  M
lauroyl LPC (bars 2 and 3). Low pH buffer was replaced with LPC-free PBS (bars 3) or with PBS supplemented with 70  M LPC (bars 2). In parallel with
fusion assay we counted the number of RBCs that remained associated with the E1-expressing cells after robust washes (shown by light blue bars). This
low-pH– and E1-dependent binding most likely reflects insertion of an E1 FL into the RBC membrane. Bars C1 and C2: control experiments similar to the
experiments shown by bars 1 but for noninfected BHK21 cells (C1) and for SIN-infected BHK21 cells with omitted low pH application (C2). These controls
show the level of binding in the absence of the low pH–activated E1 insertion. (C) Stearoyl LPC added exclusively to E1-expressing membrane inhibits its
fusion with RBCs. Bars 2: in the control experiment with no LPC added fusion between SIN E1-HAb2 cells and bound RBCs was triggered by a 5-min
application of pH 6.0 buffer. Bars 3: SIN E1-HAb2 cells were pretreated with 5  M stearoyl LPC. After washing out unbound LPC the cells were brought
in contact with RBCs. As in (2) fusion was triggered by a 5-min application of pH 6.0 buffer. Bars 1: control experiment similar to that shown by bars 3 but
with omitted low pH application. 
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tion by LPC involves its effects on interactions between E1 and
RBC membrane, we added stearoyl LPC to only E1-HAb2
cells (Fig. 5 C). Because of a low solubility in water, stearoyl
LPC, in contrast to lauroyl LPC, remains in the cell membrane
even when cells are washed with LPC-free medium (Cherno-
mordik et al., 1997). Stearoyl LPC treatment of E1-HAb2 cells
before bringing them into contact with RBCs was sufficient to
inhibit subsequent low pH–triggered fusion, confirming that
LPC inhibition does not involve disturbance of E1–target
membrane interactions.
 
Zn-arrested fusion stage
 
In contrast to LPC, which inhibits diverse fusion reactions, Zn
is a specific inhibitor of alphavirus fusion (Corver et al., 1997).
Although, as expected, 5 mM Zn did not inhibit HA fusion of
trypsin-treated HAb2 cells with bound RBCs (unpublished
data), E1-HAb2/RBC pairs treated with a low pH buffer con-
taining 5 mM Zn gave almost no fusion (Fig. 6 A, bars 2 vs.
bars 1). To inhibit fusion, Zn had to be present during the low
pH application. A 5-min preincubation of the cell pairs with
Zn, followed by washing of the cells with Zn-free EDTA-con-
taining buffer before a low pH pulse, had no effect on fusion.
Low pH pretreatment of E1-expressing membrane in the
absence of a target membrane inactivates E1 as evidenced by
the lack of fusion after the application of an additional low pH
pulse, in the presence of a target membrane (Smit et al., 1999).
In agreement with an earlier work on SFV/liposome fusion
(Corver et al., 1997), we found that Zn did not inhibit E1 inac-
tivation (Fig. 6 A, bars 1i). In the control, we treated E1-HAb2
cells with a low pH pulse, reneutralized the cells, added RBCs,
and applied a second low pH pulse. The functional inactivation
of E1 after the first low pH pulse resulted in a significant de-
crease in fusion (bars 2i). Thus, under our conditions, the num-
ber of functional SIN glycoproteins delivered to the surface of
the infected cell within the 25-min time interval between the
two low pH pulses was insufficient to produce measurable fu-
 
Figure 6.
 
ZnAS precedes LAS.
 
 In these experiments we took advantage
of the rapidness with which E1 fusion reaches its final extents under given
conditions. Collecting video microscopy images for subsequent analysis
and scoring fusion at several points in the experimental protocol (for in-
stance, before and after removal of an inhibitor) allowed us to assay fusion
extents for E1-HAb2 cells with bound RBCs under several conditions in the
same dish rather than in independent experiments. Cartoons above A, B,
and C illustrate the main finding of each figure. (A) Low pH application in
the presence of Zn yields an arrested fusion stage, where E1 is neither
irreversibly inactivated nor committed to fusion upon Zn removal. In the
control experiment E1-HAb2 cells with bound RBCs were treated by a 5-min
pH 6.0 pulse in the absence of Zn (bars 1). In the experiment on Zn inhibi-
tion (bars 2–4) fusion was first measured at the end of a 5-min pH 6.0
application in the presence of 5 mM Zn (bars 2). Fusion was next assayed
after the cells were reneutralized and Zn removed (bars 3). The cells were
treated by a second 5-min pH 6.0 pulse, and fusion was measured again
(bars 4). The lack of E1 inactivation observed in this experiment is con-
trasted with the E1 inactivation observed when low pH was applied in the
absence of the target membrane with or without Zn (bar 1i and 2i, respec-
tively). SIN E1-HAb2 cells were treated with a 5-min pulse of pH 6.0, re-
neutralized, and incubated with RBCs for 15 min. Then, a second 5-min
pulse of pH 6.0 was applied. Functional inactivation of E1 due to the first
low pH pulse lowered fusion extents observed after the second pulse. (B)
Fusion downstream of the LPC-arrested state is already insensitive to Zn. In
the control experiment (bars 1) E1-HAb2 cells with bound RBCs were
treated by a 10-min pH 6.0 pulse in the absence of fusion inhibitors. In the
experiment shown in bars 2–5, E1-HAb2 cells with bound RBCs were in-
cubated with lauroyl LPC for 5 min. Then, still in the presence of 70 
 
 
 
M
lauroyl LPC, the cells were incubated for 5 min at pH 6.0. After taking
video microscopy images for subsequent quantification (bars 2) the buffer
was replaced by the pH 6.0 buffer supplemented with LPC and Zn. Thus
the cells, while still kept at acidic pH and in the presence of LPC, were
now exposed to Zn. After 5 min incubation we again measured fusion
(bars 3). The cells were reneutralized still in the presence of LPC and Zn
and fusion was measured again (bars 4). Finally, we removed LPC and as-
sayed fusion at pH 7.4 still in the presence of Zn (bars 5). The control ex-
periments shown in bars C1 and C2 were similar to that shown by bars 5,
but we either omitted low pH application (C1) or replaced E1-HAb2 cells
with noninfected HAb2 cells (C2). (C) SIN E1-HAb2 cells with bound
RBCs acidified in the presence of both Zn and LPC do not reach LPC-
arrested stage. In the control experiment E1-HAb2 cells with bound RBCs
were treated by a 5-min pH 6.0 pulse in the absence of fusion inhibitors
(bars 1). In the experiment shown in bars 2–5, E1-HAb2 cells with bound
RBCs were incubated with both lauroyl LPC and Zn for 5 min at neutral
pH. After taking video microscopy images for subsequent quantification,
the cells were treated with a 5-min pulse of pH 6.0 still in the presence of
both LPC and Zn. Fusion was quantified (bars 2) and then again assayed
after reneutralization of the cells (bars 3) and removal of both LPC and Zn
(bars 4). Bars 5: the cells were treated with a second 5-min pH 6.0 pulse,
and fusion was measured again. The control experiments shown in bars
C1 and C2 were similar to that shown by bars 4 but we either omitted
low pH application (C1) or replaced E1-HAb2 cells with noninfected
HAb2 cells (C2). 
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sion. Similar E1 inactivation was observed when the first low
pH pulse was applied to E1-HAb2 cells in the presence of Zn
and then, after reneutralization of the cells, Zn was removed by
washes with Zn-free EDTA-containing PBS before addition of
RBCs and the second low pH pulse (bars 1i).
Low pH application to E1-HAb2/RBC pairs in the pres-
ence of Zn did not inactivate E1. Although a low pH pulse ap-
plied in the presence of Zn did not yield fusion even after Zn re-
moval (Fig. 6 A, bars 3), a second low pH pulse gave significant
fusion (bars 4). Thus, SIN E1s that were activated by low pH in
the presence of Zn and RBCs were neither irreversibly commit-
ted to fuse upon Zn removal nor irreversibly inactivated.
Because Zn, like LPC, inhibits fusion after low pH–
dependent activation of E1 but before lipid and content mix-
ing, we then tested whether Zn-arrested fusion stage (ZnAS)
comes before or after the LAS. We established the LAS by
treating E1-HAb2/RBC pairs with a low pH pulse in the pres-
ence of LPC (Fig. 6 B). Then, still at low pH and in the pres-
ence of LPC, we incubated the cells with Zn. Subsequent re-
moval of LPC, still in the presence of Zn yielded significant
fusion (bars 5), indicating that fusion stages downstream of
the LAS are already insensitive to Zn. In a complementary ex-
periment, when we treated E1-HAb2/RBC pairs with a low pH
pulse in the presence of both LPC and Zn, the cells never
reached the LAS, as evidenced by the lack of fusion upon sub-
sequent removal of both Zn and LPC (Fig. 6 C, bars 4). Fusion
observed after application of a second low pH pulse (bars 5)
confirmed that the first low pH pulse applied in the presence
of Zn and LPC did not inactivate E1. These findings indicate
that ZnAS precedes the LAS.
 
Discussion
 
Although proteins that mediate diverse fusion reactions per-
form apparently similar jobs, the pathways and the underlying
mechanisms might be radically different for different proteins.
Here, to evaluate the generality of the fusion pathways, we
have focused on alphavirus E1 and influenza HA, proteins of
class II and class I that differ drastically in their initial confor-
mations but refold toward similar final conformations upon ac-
tivation. To characterize early intermediates in E1 fusion, we
slowed down and/or arrested fusion by using suboptimal pH
and fusion inhibitors. We found E1 to establish the same set of
fusion intermediates as HA (LAS, transient hemifusion con-
nections, RH and UH, and a small and then expanding fusion
pore; Fig. 7). The only fusion phenotype specific for E1 fusion
is the ZnAS. Although HA is homotrimeric already in the ini-
tial form, E1 forms functional homotrimers only after acidifica-
tion. Zn, an inhibitor of this homotrimerization (Corver et al.,
1997), inhibits E1 fusion and does not affect HA fusion.
For E1 fusion, as for fusion mediated by HA, less acidic
pH and thus fewer low pH–activated fusion proteins are re-
quired to hemifuse the membranes rather than to open an ex-
panding fusion pore. This finding indicates that fusion proteins
of both classes (I and II) drive the entire fusion pathway, rather
than merely catalyze the merger of the contacting monolayers
of two membranes.
 
Fusion phenotypes
LAS. 
 
LAS in E1 fusion precedes membrane merger and fol-
lows all low pH–dependent stages, including the ZnAS. De-
pending on concentrations and conditions, LPC might have di-
verse effects on biological fusion. LPC inhibits many fusion
reactions by opposing the monolayer curvature that dominates
in an early stalk-like local hemifusion intermediate (for review
see Chernomordik and Kozlov, 2003). Alternatively, LPC
might block the fusion protein interactions with the target
membrane and subsequent protein restructuring required for
fusion (Stiasny and Heinz, 2004). Our results support the
former stalk-inhibiting mechanism in our system and are con-
sistent with the finding of Wilschut’s laboratory that LPC
blocks actual membrane merger in E1 fusion rather than E1 ho-
motrimerization (Wilschut, J., personal communication).
Importantly, LPC added to contacting membrane mono-
layers blocked not only their merger and resulting lipid mix-
ing but also content mixing. This finding suggests that hemi-
Figure 7. The progression of fusion phenotypes upon an
increase in the number of activated fusion proteins. In the
schematic diagram of the fusion site, the top and bottom
membranes represent a section of a fusion protein-expressing
membrane and a section of a prelabeled target cell mem-
brane, respectively. Acidification initiates restructuring of E1
and HA from very different initial conformations (see the text).
Upon increase in the number of low pH–activated fusion pro-
teins the observed fusion phenotype shifts from an initial state
with two apposing membranes, to restricted hemifusion, RH,
and then to unrestricted hemifusion, UH. The transfer of the
lipid probe from the target cell membrane through the fusion
site is first detected at UH. At still higher numbers of activated
proteins E1* and HA* fusion phenotype advances beyond
transient hemifusion phenotypes to an opening of a small
fusion pore and, finally, to an irreversible expansion of the
fusion pore. Transfer of small and large aqueous probes pre-
loaded into target cell proceeds only upon formation of small
and expanding fusion pores, respectively. LAS follows a
trigger-dependent activation of fusion proteins and precedes
the actual membrane merger. This sequence of fusion phenotypes is conserved between class I and class II fusion proteins. ZnAS, specific for E1-fusion,
precedes formation of functional E1 homotrimers (E1* HT) and LPC-arrested stage. 
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fusion is a stage of a productive fusion pathway yielding an
expanding fusion pore rather than a side product of the reac-
tion; and also indicates that E1 fusion, as HA fusion, proceeds
through hemifusion rather than through an entirely proteina-
ceous fusion pore.
 
Aborted fusion intermediates. 
 
Similarly to
earlier studies on HA fusion (Chernomordik et al., 1998;
Leikina and Chernomordik, 2000), E1 forms RH and UH inter-
mediates. The latter was documented earlier using an electro-
physiological approach for fusion between cells expressing
SFV fusion machinery and a planar lipid bilayer (Samsonov et
al., 2002). We found that both RH and UH connections in E1
fusion, as in HA fusion, dissociate with time. Thus, until the
numbers of activated E1s are high enough to form expanding
fusion pore(s), fusion intermediates remain energy intensive
and depend on protein machinery for their stabilization.
As for HA, low pH pretreatment of alphavirus glycopro-
teins in the absence of a target membrane causes inactivation of
the fusion machinery. The limited lifetime of RH and UH in-
dicates that the conformational energy of E1 gradually dis-
charges even in the presence of the target membrane. However,
in this case the inactivation is slower. Low pH–treated E1-cell/
RBC pairs, with fusion inhibited by either LPC or Zn, retain
their fusogenic potential for tens of minutes. Insertion of the E1
FL into the RBC membrane might slow down the transition of
the E1 homotrimer from an extended conformation with FL in
the target membrane to the discharged lowest-energy form, in
which the FL and the transmembrane domain are anchored
in the same membrane (Gibbons et al., 2003, 2004b).
Long-living conformations of E1 at the LAS did not
need an additional low pH application to ensure fusion after
LPC removal. In contrast, for ZnAS, E1 monomers with tar-
get-membrane–inserted FL (Corver et al., 1997) after Zn re-
moval need a second low pH pulse for fusion, suggesting that
E1 trimerization downstream of the monomer insertion is still
low pH–dependent.
 
Diverse proteins with similar final 
structures drive fusion-through-
hemifusion pathways
 
A number of important human diseases including Dengue fe-
ver are caused by viruses that enter the cells by using the class
II fusion proteins. Here, we report that these proteins catalyze
the membrane fusion pathway similar to that driven by class I
influenza virus HA. Fusion can be mechanistically coupled to
transition of fusion proteins from an “extended” conformation
of an individual homotrimeric form anchored in both mem-
branes into the hairpin post-fusion form, and/or it can be cou-
pled to lateral interactions between adjacent fusion proteins
that might already have achieved a hairpin form. Lateral in-
teractions between fusion proteins have indeed been docu-
mented, and the possible importance of these interactions in
fusion has been discussed (Blumenthal et al., 1996; Danieli et
al., 1996; Gaudin et al., 1996; Plonsky and Zimmerberg, 1996;
Chernomordik et al., 1998; Markovic et al., 1998, 2001;
Bentz, 2000; Kozlov and Chernomordik, 2002; Roche and
Gaudin, 2002; Chernomordik and Kozlov, 2003; Gibbons et
al., 2003, 2004b). Interactions between activated fusion pro-
teins assembled around the fusion site might explain the re-
striction of lipid mixing at RH (Chernomordik et al., 1998; this
paper). The hypothesis that fusion depends on the energy re-
leased by interactions between restructured proteins would ex-
plain the fusogenic activity of the large HA2 ectodomain-
based polypeptide that has a conformation similar to the post-
fusion conformation of the HA2 subunit of HA (Epand et al.,
1999; Leikina et al., 2001). This hypothesis is also consistent
with a recent finding that HA mutations that are expected to
affect only the latest stages of HA restructuring inhibit early
fusion intermediates (Park et al., 2003).
E1 and HA fusion reactions share the transient hemifu-
sion intermediates that precede an irreversible commitment to
fusion completion. We hypothesize that the early stage of en-
veloped virus infection involves these intermediates. The num-
ber of activated viral fusion proteins within the endosome
likely rises gradually upon progressive acidification of the en-
dosome content (Roederer et al., 1987). Because the opening of
a fusion pore requires more fusion proteins than does hemifu-
sion, the conditions for hemifusion should develop earlier than
those for fusion pores, suggesting that hemifusion intermedi-
ates are present in the membrane contact zone at the time of the
opening of the first fusion pore. As discussed above, interac-
tions with the target membrane slow down protein inactivation,
thus allowing additional fusion proteins to join the proteins as-
sembled around a developing fusion site. In this scenario, a rise
in the number of activated proteins, and thus an increase in the
conformational energy they might release upon fusion, drives
the transition from hemifusion to an expanding fusion pore.
Our data support the hypothesis that the final hairpin
structure shared by diverse viral fusion proteins is more impor-
tant for fusion than the initial metastable conformations of
these proteins. Because proteins involved in intracellular fu-
sion assemble into similar hairpin structures (Weber et al.,
1998), our results have important implications for the ongoing
debate about the pathway of intracellular fusion (Cherno-
mordik and Kozlov, 2003; Han et al., 2004; Szule and Coors-
sen, 2004). Several studies have concluded that intracellular
fusion, in contrast to HA-mediated fusion, starts with an open-
ing of an entirely proteinaceous fusion pore (Peters et al.,
2001; Han et al., 2004). An alternative stalk-pore hypothesis
suggests that intracellular fusion as HA-mediated fusion and
other biological fusion reactions proceeds via hemifusion in-
termediates (for review see Chernomordik and Kozlov, 2003).
This hypothesis is supported by the similarities between the ef-
fects of nonbilayer lipids on intracellular fusion, viral fusion,
and fusion of protein-free lipid bilayers (Chernomordik et al.,
1993; Vogel et al., 1993), and by studies on exocytotic fusion
in yeasts (Grote et al., 2000) and insulin granule exocytosis in
the pancreatic islet (Takahashi et al., 2002). Our finding that
dissimilar viral fusion proteins catalyze the fusion-through-
hemifusion pathway points to universality of this mechanism
of biological fusion. Thus, the fusion pathway dissected here
for E1-mediated fusion might be shared by disparate fusion re-
actions driven by diverse proteins with fundamentally similar
final hairpin structures. 
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Materials and methods
 
Cells
 
We labeled human RBCs, freshly isolated from whole blood, with fluores-
cent lipid PKH26 (Sigma-Aldrich), and with the aqueous dyes CF, FFD, and
RFD (Invitrogen) (as described in Melikyan et al., 1997b; Chernomordik et
al., 1998). RBCs were doubly labeled with PKH26 and CF; or with PKH26
and FFD; or with CF and RFD. Neither of these probes changed fusion effi-
ciency versus that observed in control without given probe.
HAb2 cells expressing A/Japan/305/57 HA (Doxsey et al., 1985)
and BHK21 cells (American Type Culture Collection, Rockville, MD) were
grown in DME containing 10% FCS, 10 mM Hepes, penicillin, and strep-
tomycin at 37
 
 
 
C.
HA is expressed in HAb2 cells in the immature HA0 form of the
HA. HA0, although competent to mediate binding with sialic acids on
RBC surface, acquires fusogenic activity only if cleaved by trypsin into ma-
ture HA1-HA2 form. If not stated otherwise, in this study we omitted the
trypsin treatment of HAb2 cells in order to leave HA in the fusion-incompe-
tent HA0 form.
In a few experiments aimed at studying HA fusion, HAb2 cells were
treated with 10 
 
 
 
g/ml trypsin (Fluka) for 10 min at 22
 
 
 
C to cleave HA0
into its fusion-competent HA1-S-S-HA2 form.
 
Infection and transfection
 
The stock of SIN strain TE was kept at 
 
 
 
80
 
 
 
C and used for infection of
BHK21 cells with low multiplicity to propagate the working virus stocks
with titer between 10
 
8
 
 and 10
 
9
 
 plaque-forming units (pfu)/ml. Working vi-
rus stocks were kept at 4
 
 
 
C for less than two weeks. HAb2 and BHK21
cells were infected with SIN from working virus stocks with multiplicity 50–
100 pfu per cell to ensure all cells were infected. The cells were used at
7–8 h after infection.
Plasmid pCB3 (Lu et al., 2001), a gift from Dr. Margaret Kielian
(Albert Einstein College of Medicine, Bronx, NY), encodes all SFV structural
proteins, capsid, p62, 6K, and E1. To transiently express the SFV proteins
in HAb2 cells, the cells were plated at 
 
 
 
70% confluence in 35-mm plates
and transfected with 2 
 
 
 
g plasmid DNA using LipofectAMINE 2000 (Invi-
trogen) according to the manufacturer’s protocol. The cells were used for
fusion assay at 30 h after transfection.
 
Fusion assay
 
All experiments were performed at 22
 
 
 
C. After two washings with PBS,
HAb2 cells were incubated for 10 min with a 1-ml suspension of RBCs
(0.01% hematocrit). HAb2 cells with 0–2 bound RBCs per cell were
washed three times with PBS to remove unbound RBCs.
To trigger fusion, E1-HAb2-cells with bound RBCs were incubated
in PBS titrated with citrate to acidic pH for 5 min, if not stated otherwise.
The low pH pulse was ended by replacement of the acidic solution with
PBS. Fusion was quantified as the ratio of dye-redistributed bound RBCs to
the total number of bound RBCs (Chernomordik et al., 1998). To charac-
terize relative frequency of UH phenotype for different pH, we normalized
the number of cell pairs that demonstrated PKH26 mixing without CF mix-
ing to the total number of the cell pairs that demonstrated PKH26 mixing.
Similarly, for NEP we plotted the difference between the number of cell
pairs that demonstrated CF and FD transfer normalized by the number of
the cell pairs that demonstrated CF transfer.
SIN-infected BHK21 cells do not bind RBCs. To study fusion be-
tween these cells, we first allowed RBCs to settle down and loosely attach
onto BHK21 cells. Then we gently and slowly replaced PBS with low pH
solution or overlay normal PBS with pretitrated acidic solution.
Even when fusion is inhibited, low pH–dependent insertion of E1 FL
into the target membrane provides an effective binding mechanism be-
tween E1-expressing membrane and target membrane (Corver et al.,
1997). To study this binding, SIN-infected BHK21 cells and RBCs were
treated with a low pH pulse in the presence of LPC. Unbound RBCs were
removed by three intensive washes with PBS. We screened at least 200
cells in six randomly selected areas of each plate. For each plate, the aver-
age number of RBCs bound to BHK21 cells was normalized by the number
of RBCs loosely associated with the cells before the washes (
 
 
 
300 RBCs).
Fusion extents reached the final levels within 1–2 min after low pH
application and were assayed by analysis of the collected video micros-
copy images taken using a microscope (model IX70; Olympus) and a
CCD camera (Photometrics CoolSNAP-fx; Roper Scientific) as the ratio of
dye-redistributed bound RBCs to the total number of bound RBCs (Cherno-
mordik et al., 1998). In all experiments, with the exception of those shown
in Fig. 2, we assayed fusion already after reneutralization. Presented data
were averaged from at least three experiments.
In our analysis of the patterns of lipid mixing to establish the com-
pletion of the lipid mixing we digitized the recorded fluorescence micros-
copy video and quantified the fluorescent area for each individual RBC/
E1-HAb2 cell pair at each time point. Full- and partial-lipid mixing pheno-
types were easily classified by eye (Fig. 2). The distinct patterns of the
spreading of the lipid probe in the full- and partial-lipid mixing phenotypes
were confirmed by the analyzing surface scans of five E1-cell/RBC pairs
for each phenotype. Because peak pixel value of final image divided by
the peak pixel value in the initial image for full lipid mixing is 55.01 
 
 
 
9.32% vs. 95.35 
 
 
 
 7.41% for partial lipid mixing, we conclude that al-
though for partial lipid mixing the highest intensity in the RBC matches that
of the initial RBC, the highest intensity for cell–RBC pairs scored as full
lipid mixing is significantly lowered by the spreading of the lipid probe. In
addition, although for cells scored as full lipid mixing no pixel in the final
image had value within 80% of peak pixel value of initial image, for par-
tial mixing 56.67 
 
 
 
 28.77% of pixels in the final image had value within
80% of the maximum pixel intensity of initial image (
 
n
 
 
 
 
 
 5 for each phe-
notype). Analysis of only final images for full versus partial lipid mixing
confirms that former phenotype presents much broader spreading of the
lipid probe in E1-cell. Percentage of pixels within 80% of maximum fluo-
rescence intensity in the final image (number of pixels within 80% of max-
imum pixel intensity in the final image divided by the total number of pix-
els in the final image) was 19.53 
 
 
 
 13.04 in full lipid mixing vs. 1.97 
 
 
 
0.88 in partial lipid mixing.
 
Application of LPC, CPZ, and ZnCl
 
2
 
70-
 
 
 
M and 5-
 
 
 
M solutions of lauroyl LPC and stearoyl LPC (Avanti Polar
Lipids, Inc.), respectively, in PBS were freshly prepared. In the experiments
with lauroyl LPC, PBS bathing the plastic-attached E1-HAb2 cells with
bound RBCs was replaced by 1 ml of lauroyl LPC-supplemented PBS
(Chernomordik et al., 1997). 5 min later, we triggered fusion by applying
low pH buffer supplemented with the same concentration of the lipid. After
5-min incubation, low pH buffer was replaced with “normal” pH PBS with
the same concentration of LPC. To study the reversibility of lauroyl LPC in-
hibition, we washed low pH-treated cells three times within 15 min by LPC-
free normal pH PBS.
In the experiments with stearoyl LPC we pretreated E1-HAb2 cells
with LPC and then removed unbound lipid by three washes with LPC-free
PBS. Then the cells were brought into contact with untreated RBCs. Fusion
was triggered by a 5-min application of LPC-free buffer, pH 6.0.
CPZ (Sigma-Aldrich) was prepared as a 0.5-mM solution in PBS.
E1-HAb2-cells with bound RBCs were treated by low pH buffer, returned
to neutral pH and immediately or 40 min later exposed to CPZ-containing
solution for 60 s. Fusion analysis was performed in CPZ-free PBS.
A working solution of 5 mM ZnCl
 
2
 
 was prepared from 1 M stock in
the buffer HNE (25 mM Hepes, 150 mM NaCl, and 0.1 mM EDTA) and
titrated to normal or acid pH with citric acid. To remove Zn we washed
the cells with HNE supplemented with 6 mM EDTA for 1 min and replaced
it with PBS.
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